In the neoadjuvant chemotherapy group , patients received oral administration of Xeloda 1000 mg/m ( 2 ) twice a day on days 1-14 and intravenous infusion of oxaliplatin 130 mg/m ( 2 ) on day 1 ( XELOX regimen ) .